
Results
269
Most Popular Stocks on the market
269 companies
Samsung BiologicsLtd
Market Cap: ₩74.5t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,609,000.00
7D
9.0%
1Y
2.5%
Celltrion
Market Cap: ₩48.3t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩210,500.00
7D
13.3%
1Y
28.2%
ALTEOGEN
Market Cap: ₩22.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩327,500.00
7D
22.7%
1Y
-2.0%
Samsung Epis Holdings
Market Cap: ₩10.6t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩426,500.00
7D
10.5%
1Y
n/a
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩90,500.00
7D
13.4%
1Y
-8.4%
Yuhan
Market Cap: ₩6.4t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩85,600.00
7D
14.4%
1Y
-22.9%
Hanmi Pharm
Market Cap: ₩5.2t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩413,000.00
7D
9.3%
1Y
46.5%
ABL Bio
Market Cap: ₩5.0t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩89,100.00
7D
10.8%
1Y
15.4%
Sam Chun Dang Pharm
Market Cap: ₩4.5t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩191,700.00
7D
14.6%
1Y
4.8%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩417,000.00
7D
8.5%
1Y
-37.7%
LigaChem Biosciences
Market Cap: ₩4.3t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩116,900.00
7D
6.4%
1Y
-21.0%
Peptron
Market Cap: ₩4.3t
Engages in the development of peptide-based medicines.
A087010
₩184,400.00
7D
6.1%
1Y
-39.6%
Caregen
Market Cap: ₩3.2t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩66,000.00
7D
2.6%
1Y
37.9%
Voronoi
Market Cap: ₩3.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩176,500.00
7D
28.4%
1Y
50.2%
Hugel
Market Cap: ₩3.1t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩282,500.00
7D
9.5%
1Y
-14.7%
SK bioscienceLtd
Market Cap: ₩2.9t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩37,500.00
7D
8.2%
1Y
-17.7%
Hanall Biopharma
Market Cap: ₩2.9t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩56,900.00
7D
9.4%
1Y
110.0%
D&D Pharmatech
Market Cap: ₩2.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩60,900.00
7D
-6.0%
1Y
83.2%
OliX Pharmaceuticals
Market Cap: ₩2.8t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩131,900.00
7D
10.1%
1Y
164.1%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩108,000.00
7D
7.2%
1Y
19.3%
Celltrion Pharm
Market Cap: ₩2.0t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩46,100.00
7D
10.6%
1Y
-10.1%
Mezzion PharmaLtd
Market Cap: ₩1.9t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩63,000.00
7D
15.8%
1Y
72.6%
Aimed Bio
Market Cap: ₩1.7t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩26,800.00
7D
10.7%
1Y
n/a
L&C BIOLTD
Market Cap: ₩1.7t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩63,500.00
7D
8.2%
1Y
98.4%
Kolon TissueGene
Market Cap: ₩1.7t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩19,620.00
7D
23.2%
1Y
-48.4%
Orum Therapeutics
Market Cap: ₩1.5t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩71,000.00
7D
22.6%
1Y
200.2%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩132,700.00
7D
10.6%
1Y
-0.8%
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩23,400.00
7D
6.6%
1Y
7.8%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩130,100.00
7D
5.3%
1Y
0.6%
Seegene
Market Cap: ₩1.5t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩32,550.00
7D
16.5%
1Y
19.7%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
8.1%
1Y
18.7%
JS Link
Market Cap: ₩1.4t
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩41,000.00
7D
24.6%
1Y
144.2%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩42,250.00
7D
8.6%
1Y
-3.5%
Qurient
Market Cap: ₩1.1t
A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.
A115180
₩26,250.00
7D
19.9%
1Y
147.9%
Rznomics
Market Cap: ₩974.0b
Develops RNA based gene therapies for cancers and intractable diseases.
A476830
₩34,950.00
7D
11.0%
1Y
n/a
DongKook Pharmaceutical
Market Cap: ₩967.6b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩21,450.00
7D
17.7%
1Y
23.1%